Placing The Patient First In Clinical Trials

Today biopharmaceutical companies are transforming the focus of clinical trials, not viewing patients as subjects for generating data, but as informed collaborators whose participation is core to the overall success of trials. The industry is increasingly adopting a patient-centric drug development model, focusing more on patients and addressing their needs and convenience. This article discusses ways to adopt patient-centered drug development, changing the corporate culture and trial design, understanding patient needs and incorporating them into trials, and leveraging technology to conduct remote patient-centric clinical trials.